Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in... Cardiol Ther (2019) 8:55–67 https://doi.org/10.1007/s40119-019-0126-5 ORIGINAL RESEARCH Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention . . . . Mathijs C. Bodde Maaike P. J. Hermans Ron Wolterbeek Christa M. Cobbaert . . Arnoud van der Laarse Martin J. Schalij J. Wouter Jukema Received: October 17, 2018 / Published online: February 13, 2019 The Author(s) 2019 primary percutaneously coronary intervention ABSTRACT (pPCI). Methods: Baseline blood samples were Introduction: Hypercholesterolemia is a well- obtained from all patients admitted between known risk factor for developing atherosclerosis 2004 and 2014 with STEMI who underwent and subsequently for the risk of a myocardial pPCI. Patients were excluded in case of out of infarction (MI). Moreover, it might also be hospital cardiac arrest, treatment delay of at related to the extent of damaged myocardium least 10 h or no complete reperfusion after pPCI in the event of a MI. The aim of this study was in the culprit vessel. Peak creatine kinase (CK) to evaluate the association of baseline low level was used for infarct size estimation, density lipoprotein-cholesterol (LDL-c) level defined as the maximal value during admission. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Download PDF
13 pages

Loading next page...
 
/lp/springer-journals/plasma-ldl-cholesterol-level-at-admission-is-independently-associated-RZgc21PTtY

References (51)

Publisher
Springer Journals
Copyright
Copyright © 2019 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-019-0126-5
Publisher site
See Article on Publisher Site

Abstract

Cardiol Ther (2019) 8:55–67 https://doi.org/10.1007/s40119-019-0126-5 ORIGINAL RESEARCH Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention . . . . Mathijs C. Bodde Maaike P. J. Hermans Ron Wolterbeek Christa M. Cobbaert . . Arnoud van der Laarse Martin J. Schalij J. Wouter Jukema Received: October 17, 2018 / Published online: February 13, 2019 The Author(s) 2019 primary percutaneously coronary intervention ABSTRACT (pPCI). Methods: Baseline blood samples were Introduction: Hypercholesterolemia is a well- obtained from all patients admitted between known risk factor for developing atherosclerosis 2004 and 2014 with STEMI who underwent and subsequently for the risk of a myocardial pPCI. Patients were excluded in case of out of infarction (MI). Moreover, it might also be hospital cardiac arrest, treatment delay of at related to the extent of damaged myocardium least 10 h or no complete reperfusion after pPCI in the event of a MI. The aim of this study was in the culprit vessel. Peak creatine kinase (CK) to evaluate the association of baseline low level was used for infarct size estimation, density lipoprotein-cholesterol (LDL-c) level defined as the maximal value during admission.

Journal

Cardiology and Therapy – Springer Journals

Published: Feb 13, 2019

There are no references for this article.